Importance-Resting state functional connectivity magnetic resonance imaging (rs-fcMRI) has great potential for characterizing pathophysiological changes during the preclinical phase of Alzheimer's disease (AD).
Introduction
Accumulation of amyloid β (Aβ) and tau proteins, the pathologic hallmarks of Alzheimer's disease (AD), starts years before clinical onset [1] [2] [3] [4] . Pathophysiological abnormalities in the preclinical phase of AD may be detected using cerebrospinal fluid (CSF) and/or neuroimaging biomarkers. CSF biomarkers have been recognized as key elements of research criteria for the preclinical phases of AD 5, 6 . Resting state functional connectivity magnetic resonance imaging (rs-fcMRI) 7 , a non-invasive measure of brain integrity, has considerable potential in studies of preclinical AD 5, 8,9 . CSF Aβ 42 and amyloid imaging tracers such as Pittsburgh Compound B (PiB) measure amyloid burden in the brain 10, 11 . Both CSF tau and phosphorylated forms of tau (ptau) are hypothesized to reflect neurodegeneration and/or tau pathology 12, 13 . Symptomatic AD patients typically have a characteristic biomarker profile consisting of reduced CSF Aβ 42 , increased PiB binding in the brain, and elevated CSF tau and ptau 11, 14 . Cognitively normal individuals can also exhibit biomarker evidence of AD pathology, with Aβ abnormalities more prevalent than alterations in tau or ptau [15] [16] [17] .
rs-fcMRI abnormalities have been consistently observed in the default mode network (DMN) in symptomatic AD patients (for review see Greicius 18 ). Aβ preferentially deposits in cortical association areas that prominently include nodes of the DMN 19 . Tau accumulation initially occurs in the limbic system 20 , a sub-component of the DMN 21 . More recent rs-fcMRI investigations have detected DMN changes in asymptomatic individuals with increased amyloid deposition using PiB [22] [23] [24] . However, the association between functional connectivity in the DMN and CSF biomarker abnormalities requires further study 25, 26 .
We investigated the relationship between CSF biomarkers (e.g., Aβ 42 and ptau 181 ) and rs-fcMRI in a large sample of cognitively normal individuals (N=207). We hypothesized that decreased CSF Aβ 42 and increased ptau 181 levels would be associated with reduced DMN functional connectivity.
Materials and Methods

Participants
Participants were community-dwelling volunteers enrolled in aging and memory studies at the Charles F. and Joanne Knight Alzheimer's Disease Research Center at Washington University in Saint Louis. Detailed information regarding recruitment has been previously published 27 . Inclusion criteria were: 1) completion of MRI scans and CSF collection within 12 months of clinical assessment, 2) normal cognition, determined by a Clinical Dementia Rating (CDR) of 0 28 , at the assessments closest to the time of MRI scanning and CSF collection. Individuals were excluded if they had a medical or psychiatric illness that could affect longitudinal follow-up or adversely affect cognitive performance. All studies were approved by the Human Research Protection Office with written informed consent obtained from all participants.
Clinical assessment
An experienced clinician conducted separate semi-structured interviews with the participant and an informant, and determined the presence or absence of dementia based on the principle of intra-individual cognitive decline relative to prior functional level 29 . Only CDR 0 subjects (i.e., cognitively normal) were included in the primary analysis. 207 cognitively normal participants had both MRI scans and CSF collection within 12 months of clinical assessment. Demographic information and CSF biomarker profiles are provided in Table 1 .
Genotyping DNA was extracted from peripheral blood samples. Genotyping for apolipoprotein E (APOE) was performed using procedures previously described 30 .
CSF collection and analysis
CSF (20-30 mL) was collected at 8:00 AM after overnight fasting as previously described 10 . CSF samples were analyzed for Aβ 42 , tau, and ptau 181 by plate-based enzyme-linked immunosorbent assay (INNOTEST; Innogenetics, Ghent, Belgium). Since CSF tau was highly correlated with CSF ptau 181 in the present cohort (Spearman rho = 0.836, p<0.001), we report only CSF ptau 181 in relation to functional connectivity. In addition, neither CSF tau nor ptau 181 was correlated with CSF Aβ 42 (both p ≥ 0.469).
Image acquisition and pre-processing of rs-fcMRI data
Participants were scanned using a Siemens Trio 3T Trio scanner (Siemens Medical Systems, Erlangen, Germany). Two high-resolution structural scans were obtained with T1-weighted magnetization-prepared rapid gradient echo (MPRAGE) sequence (echo time [TE] = 16 msec, repetition time [TR] = 2,400 msec, inversion time [TI] = 1,000 msec, flip angle = 8°, 256 × 256 acquisition matrix, 1 × 1 × 1 mm voxels). High-resolution T2-weighted fast spin echo (FSE) images were acquired (TE = 455 msec, TR = 3,200 msec, 256 × 256 acquisition matrix, 1 × 1 × 1 mm voxels). Two resting rs-fcMRI scans (164 volumes each) were acquired using a gradient echo sequence (TE = 27 msec, TR = 2.2 sec, 64 × 64 acquisition matrix, flip angle = 90°). Thirty-six axial slices with no gap parallel to the anterior-posterior commissure line with approximately 4.0 mm cubic voxels provided whole-brain coverage. Participants were instructed to fixate on a visual cross-hair, remain still, and not fall asleep during scanning. Details concerning rs-fcMRI preprocessing are provided in eMethod.
Quality assurance (QA) of rs-fcMRI data
The QA procedures for rs-fcMRI data have been previously described 31, 32 . Briefly, fMRI data quality was assessed by computing voxelwise root mean squared (rms) temporal variance (sd) averaged over the whole brain. Individuals with a mean preprocessed fMRI signal sd > 2.5% (before nuisance regression) or rms head motion > 1.25 mm were excluded. In addition, frames (volumes) with high variance were identified and removed 33, 34 . The number of frames excluded due to high variance did not correlate with any CSF variable (eMethod).
Definition of regions of interest
Generation of regions of interest (ROIs) within the DMN have been previously described 32 . Briefly, rs-fcMRI data were analyzed from a separate cohort of eight participants with mild AD dementia (CDR 1) and eight cognitively normal participants (CDR 0). A 6-mm-radius sphere centered on the PCC (MNI coordinates: −2, −54, 16) was used as a seed. Correlation maps using this PCC seed were obtained for each participant and averaged separately for the mild AD and cognitively normal groups. A group difference map was produced by subtracting the averaged map of mild AD participants from cognitively normal individuals. Participants with mild AD dementia showed reduced correlation between the PCC and other DMN nodes including the retrosplenial cortex extending to the precuneus, the left and right inferior parietal lobules (IPL), the left and right medial temporal lobe (MTL), and medial prefrontal cortex (MPFC) (see eTable 1). 6-mm-radius spheres centered on peak voxels from each region were subsequently used in the present ROI-based analyses.
ROI-based investigation of relationships between CSF biomarker levels and DMN integrity
Treating each of the CSF biomarkers as continuous variables, Spearman partial correlation was used to assess the relationships between CSF biomarkers and DMN integrity. ROIbased functional connectivity measures of the DMN (i.e., PCC-RSC, PCC-LIPL, PCC-RIPL, PCC-MPFC, PCC-LMTL and PCC-RMTL) were analyzed separately for each CSF biomarker controlling for potential confounding effects. Since prior work has suggested that APOE genotype (the presence or absence of ε4 allele) might impact CSF Aβ 42 35 and DMN functional connectivity 36, 37 , we first assessed whetherAPOE ε4 status modulated the relationship between CSF Aβ 42 and DMN functional connectivity. The entire cohort of cognitively normal participants was divided into two sub-groups according to the presence or absence of at least one APOE ε4 allele. The correlations (Spearman's rho) between CSF Aβ 42 and functional connectivity were computed separately for the two sub-groups. For a given CSF Aβ 42 -functional connectivity relationship, we compared the correlations obtained from APOE ε4 non-carriers to APOE ε4 carriers, and reported these correlations if a significant difference was found. Otherwise, the relationship between CSF Aβ 42 and functional connectivity was assessed within the entire cohort after adjusting for age, PCC and MTL volumes separately, and CSF tau/ptau 181 levels. Details of the comparisons of correlation coefficients between APOE ε4 non-carriers and carriers are provided in eMethod. Moreover, the associations between CSF ptau 181 and functional connectivity were examined after adjusting for age, PCC and MTL volumes separately, and CSF Aβ 42 levels. Computation was implemented using R (Version 2.15.1) 38 with a statistical threshold for significance of p < 0.05, uncorrected for multiple comparisons.
Voxel-wise whole-brain investigation of relationships between CSF biomarker levels and DMN integrity
Participants were classified as CSF Aβ 42 negative (>500 pg/ml) or positive (≤500 pg/ml), and CSF ptau 181 negative (<80 pg/ml) or positive (≥80 pg/ml) 35 . Correlation maps were generated for each participant using the PCC as a seed region. Fisher z-transformed subjectlevel correlation maps were submitted to second-level random effects analyses to identify voxels within a grey matter mask showing significant group contrast effects. These secondlevel analyses were conducted using two-sample t-tests implemented in Statistical Parametric Mapping 8 (SPM8) (http://www.fil.ion.ucl.ac.uk/spm/software/spm8/); the resulting t-maps were thresholded at a cluster-level significance of p < 0.05.
Effects of PCC and MTL volumes on rs-fcMRI changes
To assess the likelihood that observed functional connectivity changes were attributed to PCC and MTL atrophy, high-resolution structural scans were processed using FreeSurfer (Version 5.10) (http://surfer.nmr.mgh.harvard.edu) to obtain regional volumes from the isthmus cingulate gyrus (i.e., PCC) and the hippocampus, entorhinal cortex and parahippocampal gyrus (combined to form MTL volume) (see eMethod). Each PCC and MTL volume was correlated separately for CSF Aβ 42 and ptau 181 using a Spearman correlation. Specifically, CSF Aβ 42 -volumetric relationships were assessed after adjustment for age and CSF ptau 181 , and CSF ptau 181 -volumetric relationships were evaluated after adjustment for age and CSF Aβ 42 .
Results
ROI-based measures of functional connectivity correlated with CSF biomarker levels
Functional connectivity between the PCC and the 6 independently defined DMN ROIs was computed using standard methodology 31 . Spearman partial correlations were computed between the functional connectivity measures and each CSF biomarker with adjustment for potential confounding factors (see Table 2 for results). Correlations (Spearman's rho) between CSF Aβ 42 and functional connectivity were not significantly different between APOE ε4 non-carriers and carriers (all p ≥ 0.154)(eTable 2). We therefore pooled APOE ε4 carriers and non-carriers in subsequent analyses. Decreased CSF Aβ 42 was associated with reduced functional connectivity between the PCC:left MTL (rho = 0.155, p = 0.026) and the PCC:right MTL (rho = 0.231, p < 0.001) after adjusting for age, PCC and MTL volumes separately, and CSF ptau 181 . Increased CSF ptau 181 levels were associated with reduced functional connectivity between the PCC:left MTL (rho = −0.182, p = 0.008), and a trend level decrease for the PCC:right MTL (rho = −0.122, p = 0.081), and the PCC-MPFC (rho = −0.115, p = 0.100) after adjusting for age, PCC and MTL volumes separately, and CSF Aβ 42 levels. All other associations between functional connectivity and CSF Aβ 42 or CSF ptau 181 levels were not significant (all p ≥ 0.174).
Topographies of altered functional connectivity as a function of CSF biomarker
In the voxel-wise analyses, each CSF biomarker was treated as a dichotomous variable. Group-contrast correlation maps are shown in Figure 1 . CSF Aβ 42 -positive pariticipants (≤500 pg/ml) exhibited lower positive correlations (reduced functional connectivity) between the PCC and left MTL compared to CSF Aβ 42 -negative participants ( Figure 1A , and eTable 3). The same group contrast revealed a reduction in the magnitude of anticorrelations between the PCC and left supramarginal gyrus, and between the PCC and right inferior frontal gyrus (at a trend-level). Parallel effects of CSF biomarkers on positive correlations and anticorrelations are consistent with previous rs-fcMRI results obtained in symptomatic (CDR 0.5 and CDR 1) individuals 31 . Relative to CSF ptau 181 -negative participants, CSF ptau 181 -positive (≥80 pg/ml) participants exhibited lower positive correlations between the PCC and left angular gyrus, and between the PCC and left MTL (at a trend-level). A reduction in the magnitude of anticorrelations was also observed between the PCC and right postcentral gyrus ( Figure 1B, and eTable 3) . Other functional connectivity changes that did not reach cluster-level significance (p < 0.05) are listed in eTable 3.
Relationship between CSF biomarkers and PCC and MTL volumetrics
We computed PCC and MTL volumes using FreeSurfer-defined ROIs. CSF Aβ 42 was correlated with MTL (Spearman rho = 0.172, p = 0.012) but not PCC volume (Spearman rho = −0.044, p = 0.530) after adjustment for age and CSF ptau 181 . CSF ptau181 was not correlated with MTL or PCC volumes (all p ≥ 0.100).
Comment
We assessed the relationship between neuroimaging indices of brain functional network integrity and well-validated CSF biomarkers of AD pathology in cognitively normal old individuals. We demonstrated that decreased CSF Aβ 42 and increased CSF ptau 181 were associated with reduced magnitude of correlations in the DMN and within areas normally anti-correlated to the DMN. The most prominent decreases in functional connectivity were seen between the PCC and MTL regions. The effects of CSF Aβ 42 , CSF tau and ptau 181 , each of which independently affected DMN functional connectivity, were not attributable to age or structural atrophy in the PCC and MTL.
Amyloid plaques preferentially form within DMN regions including the PCC and precuneus, anterior prefrontal, lateral parietal and temporal regions 11, 19 . Reduced functional connectivity among these regions [22] [23] [24] 39 is well documented in cognitively normal elderly with high amyloid burden [22] [23] [24] 39 . However, the MTL is not an early site of plaque formation. Therefore, the link between reduced PCC-MTL functional connectivity and lower CSF Aβ 42 may be related to other mechanims. One possibility is that functional connectivity changes are more related to soluble than fibrillary forms of Aβ. Animal studies have demonstrated that oligomeric Aβ directly impairs synaptic function or causes synaptic loss, particularly within the MTL 40, 41 . We observed that reduced CSF Aβ 42 was associated with volume loss in the MTL but not PCC, which is consistent with the oligomere toxicity hypothesis. Further work examining CSF Aβ 42 in relation to soluble forms of Aβ are warranted. Another possibility is that the preferential involvement of PCC-MTL functional connectivity is related to the experimental findings demonstrating that regional Aβ deposition causes aberrant electrophysiological activity within spatially distributed functional networks 4243 . Given that Aβ preferentially accumulates in the PCC, we speculate that reduced PCC-MTL functional connectivity could be a consequence of aberrant activity in extensive anatomical connections between the PCC and MTL 44 .
The association between CSF ptau and functional connectivity may be related to the progression of tangle pathology in the brain. Neurofibrillary tangles composed of ptau initially form in the trans-entorhinal cortex and spread in a topographically stereotypical manner, possibly via anatomic connections 20 . In our data, increased CSF ptau levels were associated with reduced functional connectivity within the anatomic pathways through which neurofibrillary tangles spread 45 . We suspect that the inverse relationship of CSF ptau and functional connectivity may be driven by the progression of tangle pathology. In cognitively normal individuals, tangles are largely confined to the MTL 1 and these tangles are associated with little or no neuronal loss 46 . In contrast, patients with very mild AD dementia (CDR0.5) have substantial neuronal loss (30-50%) in the entorhinal cortex 46, 47 . It is possible that elevated CSF ptau may be associated with neuronal and synaptic loss in the MTL that is not yet sufficent to produce overt clinical symptoms and not detectable by the present volumetric measure but is detectable at the group level using rs-fcMRI.
The convergent effects of decreased CSF Aβ 42 and increased CSF ptau 181 on the DMN provides insights into the early pathophysiology of AD. The PCC and MTL are two critical nodes of a larger network supporting episodic memory 48 . Stronger PCC-MTL functional connectivity is associated with better performance on memory tasks 49 . Structural atrophy of the PCC-MTL pathway is consistent with commonly recognized memory impairments in AD 50 . Thus, the available data suggest that memory impairment in the early phases of AD may be attributable to the convergent effects of both amyloid and tau pathology.
The present study has several limitations. Using both hypothesis-driven ROI-based analysis and voxel-wise whole-brain exploration, we observed that abnormal levels of CSF Aβ 42 and ptau 181 were associated with reduced functional connectivity within nodes of the DMN, most prominently in PCC:MTL measures. However, the effect sizes were modest, most likely because we studied pre-symptomatic individuals. Replication of our findings is needed in additional independent samples. Although we found no evidence that rs-fcMRI changes were attributable to PCC or MTL atrophy, we note that volumetric measurements were derived from FreeSurfer-defined regions that did not completely overlap with ROIs used in the rs-fcMRI analysis. In addition, volumetric changes in other DMN regions (besides the PCC and MTL) were not included in our analysis. Further studies using more rigorous approaches to control for the effects of structural brain changes are warranted. Patients with the mild symptomatic AD exhibit changes in multiple resting state networks (RSNs) 31 . Further work is warranted to examine the effects of CSF biomarker abnormalities in RSNs other than the DMN.
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